A Novel and Practical Screening Tool for the Detection of Silent Myocardial Infarction in Patients With Type 2 Diabetes | Zendy

Peter Swoboda | Zendy; Adam K McDiarmid | Zendy; Bara Erhayiem | Zendy; Philip Haaf | Zendy; Ananth Kidambi | Zendy; Graham Fent | Zendy; Laura E Dobson | Zendy; Tarique A Musa | Zendy; Pankaj Garg | Zendy; Graham Law | Zendy; Mark T. Kearney | Zendy; Julian H. Barth | Zendy; Ramzi Ajjan | Zendy; John P. Greenwood | Zendy; Sven Plein | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

A Novel and Practical Screening Tool for the Detection of Silent Myocardial Infarction in Patients With Type 2 Diabetes

Author(s) -

Peter Swoboda,

Adam K McDiarmid,

Bara Erhayiem,

Philip Haaf,

Ananth Kidambi,

Graham Fent,

Laura E Dobson,

Tarique A Musa,

Pankaj Garg,

Graham Law,

Mark T. Kearney,

Julian H. Barth,

Ramzi Ajjan,

John P. Greenwood,

Sven Plein

Publication year - 2016

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2016-1318

Subject(s) - medicine , cardiology , asymptomatic , myocardial infarction , ejection fraction , type 2 diabetes , receiver operating characteristic , diabetes mellitus , natriuretic peptide , population , heart failure , environmental health , endocrinology

Silent myocardial infarction (MI) is a prevalent finding in patients with type 2 diabetes and is associated with significant mortality and morbidity. Late gadolinium enhancement (LGE) by cardiovascular magnetic resonance (CMR) is the most validated technique for detection of silent MI, but is time-consuming, costly, and requires administration of intravenous contrast. We therefore planned to develop a simple and low-cost population screening tool to identify those at highest risk of silent MI validated against the CMR reference standard.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research